Titlebook: Breast Cancer Research and Treatment; Innovative Concepts Ouissam Al Jarroudi,Khalid El Bairi,Giuseppe Curig Book 2023 The Editor(s) (if ap

–scent

竊喜

,Antibody–Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast Cancer,erapy. Despite recent advances in drug discovery, its management is still a challenge for clinicians, illuminating the unmet need to develop novel treatment approaches. Antibody–drug conjugates (ADC) are innovative oncology drugs that combine the specificity of monoclonal antibodies and the high eff

聰明

animated

Eclampsia

Collected

Assessment and Response to Neoadjuvant Treatments in Breast Cancer: Current Practice, Response Moniy, it was introduced 50 years ago to downsize locally advanced (inoperable) BCs. NAT are now widespread and so effective to be used also at the early stage of the disease. NAT are heterogeneous in terms of therapeutic patterns, class of used drugs, dosage, and duration. The poly-chemotherapy regimen

蒙太奇